Reduction of inflammatory responses against adenoviral vectors to improve safety and efficacy of gene therapy for Dravet syndrome (RIRADS)

Project information

Research project called Reduction of inflammatory responses against adenoviral vectors to improve safety and efficacy of gene therapy for Dravet syndrome (RIRADS) of the Research Group on Gene Therapy for Congenital Encephalopathies of CIMA of the University of Navarra.

PI: Ruben Hernandez-Alcoceba.

Funding agency: Fundacion Síndrome de Dravet (Spain).

Duration: 01/06/2021-01/06/2022. 

• Start date: June 1, 2021
• End date: June 1, 2022
• Nature of project: National